Related Articles
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative
LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome
Silencing of zinc finger protein 703 inhibits medullary thyroid carcinoma cell proliferation in vitro and in vivo
Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis